{"id":510051,"date":"2021-07-06T22:14:04","date_gmt":"2021-07-07T02:14:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/"},"modified":"2021-07-06T22:14:04","modified_gmt":"2021-07-07T02:14:04","slug":"investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/","title":{"rendered":"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Athira Pharma, Inc."},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, July  06, 2021  (GLOBE NEWSWIRE) &#8212; The law firm of <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=97rlWHPDX99Arfgsg6vD7uLAkjMGO2ekzdJnIDilh11JYxh6Rzy8puWRokpAfqh6hACOcOaGZZOei6wyVjwStw==\" rel=\"nofollow noopener\" target=\"_blank\">Kirby McInerney LLP<\/a> announces that a class action lawsuit has been filed in the U.S. District Court for the Western District of Washington on behalf of those who acquired Athira Pharma, Inc. (\u201cAthira\u201d or the \u201cCompany\u201d) (NASDAQ: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ot2PYy1stGkq2CN8FQpxte9UvYs-o2YZ7wZiip_FIjocLkDCNW54Auv05-XoTxZLzeAnYlETGj1UMtvxbeOYE2OPf88vgxMSOOcYOlFAJTV0sZusvZ0kXRKbDpTHQ10Z\" rel=\"nofollow noopener\" target=\"_blank\">ATHA<\/a>) securities from September 18, 2020 through June 17, 2021, inclusive (the \u201cClass Period\u201d). Investors have until August 24, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.<\/p>\n<p align=\"justify\">In September 2020, the Company closed its initial public offering, in which the Company sold and issued 12,000,000 shares of common stock at a price to the public of $17.00 per share. In January 2021, the Company completed a follow-on public offering of its common stock. As part of the follow-on offering, the Company issued and sold 4,000,000 shares of its common stock at a public offering price of $22.50 per share.<\/p>\n<p align=\"justify\">On June 17, 2021, Athira issued a press release announcing that the Company\u2019s Chief Operating Officer had \u201cassumed day-to-day leadership responsibilities for the Company, effective immediately.\u201d The Company further disclosed that the Board of Directors placed the President and Chief Executive Officer Leen Kawas (\u201cKawas\u201d), \u201con temporary leave pending a review of actions stemming from doctoral research [the CEO] conducted while at Washington State University.\u201d The Company also disclosed that the \u201cBoard has formed an independent special committee to undertake this review.\u201d On this news, Athira\u2019s share price declined by $7.09 per share, or approximately 38.9%, from $18.24 per share to close at $11.15 per share on June 18, 2021.<\/p>\n<p align=\"justify\">The lawsuit alleges that Defendants made materially false and misleading statements and omitted to material adverse facts regarding the Company\u2019s business. Specifically, Defendants failed to disclose to investors: (1) that the research conducted by Kawas, which formed the foundation for Athira\u2019s product candidates and intellectual property, was tainted by Kawas\u2019 scientific misconduct, including the manipulation of key data; and (2) that, as a result of the foregoing, Defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially misleading and omitted material facts necessary in order to make the statements made not misleading.<\/p>\n<p align=\"justify\">If you purchased or otherwise acquired Athira securities, have information, or would like to learn more about these claims, please contact\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8JplTRiedeapVIaMoTwId44LLEa37H0O7eMO8jSjxiNP9vJ_FgNijyUB0FWczCuAXt6LlbAsYRZTDnWVLO4UL8A3lvokzWrUmtCVRAuOlkw=\" rel=\"nofollow noopener\" target=\"_blank\"><u>Thomas W. Elrod<\/u><\/a> of<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CZL_LLu7WBBScl5l03L8QeLu_agbSmKVtHEEPLAmVq7WyJpHupK0tKQuvxQjvHgJyxu3GJ-eFwSaAiBG3XqThw==\" rel=\"nofollow noopener\" target=\"_blank\"><u>Kirby McInerney LLP<\/u><\/a> at 212-371-6600, by email at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vUO28AsZjLDg6ybF2vm40Z1M8XmQv2uKYXWhyNjtiR4TYTTrdmUZRKsUY4DQcJvF2JkIGpC9O6mUWg29JqUbNZlaEkC9kBCtVnKVB2K957g=\" rel=\"nofollow noopener\" target=\"_blank\"><u>investigations@kmllp.com<\/u><\/a>, or by filling out this <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0QgefY2-lLM5dwsJm1e7azS826yDZctNyiVtuDZXP5uWnoFAmmVUQft2jnk5Zzk_jAEjJTFfH5jM70pqC8RU62qKsE50grVHdXYHUap1wyfDV2nkoeqauBf56BT3Q7Dj\" rel=\"nofollow noopener\" target=\"_blank\">contact form<\/a>, to discuss your rights or interests with respect to these matters without any cost to you.<\/p>\n<p align=\"justify\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=97rlWHPDX99Arfgsg6vD7hoFiX9h_t9J37XfHNtNpXZ1JtXwJLe88mCj6UEgX1v09DloyaX24WhG6nd1elK0Nw==\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <u>Kirby McInerney LLP<\/u><br \/>\n        <\/a> is a New York-based plaintiffs\u2019 law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm\u2019s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP\u2019s website:<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mv4hDTwx_vsE8hXEvf8opPQNk8HXFvDICS-7PFJxEiL6T7dhMH6Q0tE2Is2txqJ4fqqfgZu-YV70aZlVBEiTGQ==\" rel=\"nofollow noopener\" target=\"_blank\"><u>http:\/\/www.kmllp.com<\/u><\/a>.<\/p>\n<p align=\"justify\">This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p>\n<p align=\"justify\">Contacts<br \/>Kirby McInerney LLP<br \/>Thomas W. Elrod, Esq.<br \/>212-371-6600<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nUGq4Lt7hIYFZk8qU3l8r4xb-3TRt3BhuN5nY-yXFG2E8lQPedc4ziDD2pCr9ftgAeCPPazWfU3PBaKexlFD7g==\" rel=\"nofollow noopener\" target=\"_blank\"><u>https:\/\/www.kmllp.com<\/u><\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vUO28AsZjLDg6ybF2vm40Z1M8XmQv2uKYXWhyNjtiR4ZlY3w7As-qMYhvMwjG004vCij_hwcm86f_zmsxgRSikwk1FVzswdLzjk9pwT08X8=\" rel=\"nofollow noopener\" target=\"_blank\"><u>investigations@kmllp.com<\/u><\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NjI0OCM0Mjg1NTg1IzIwMjA2Njk=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/8b56c6e2-f5c3-457c-98df-882c3aef92d9\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, July 06, 2021 (GLOBE NEWSWIRE) &#8212; The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Western District of Washington on behalf of those who acquired Athira Pharma, Inc. (\u201cAthira\u201d or the \u201cCompany\u201d) (NASDAQ: ATHA) securities from September 18, 2020 through June 17, 2021, inclusive (the \u201cClass Period\u201d). Investors have until August 24, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit. In September 2020, the Company closed its initial public offering, in which the Company sold and issued 12,000,000 shares of common stock at a price to the public of $17.00 per share. In January 2021, the Company &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Athira Pharma, Inc.&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-510051","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Athira Pharma, Inc. - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Athira Pharma, Inc. - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, July 06, 2021 (GLOBE NEWSWIRE) &#8212; The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Western District of Washington on behalf of those who acquired Athira Pharma, Inc. (\u201cAthira\u201d or the \u201cCompany\u201d) (NASDAQ: ATHA) securities from September 18, 2020 through June 17, 2021, inclusive (the \u201cClass Period\u201d). Investors have until August 24, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit. In September 2020, the Company closed its initial public offering, in which the Company sold and issued 12,000,000 shares of common stock at a price to the public of $17.00 per share. In January 2021, the Company &hellip; Continue reading &quot;INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Athira Pharma, Inc.&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-07T02:14:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NjI0OCM0Mjg1NTg1IzIwMjA2Njk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Athira Pharma, Inc.\",\"datePublished\":\"2021-07-07T02:14:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\\\/\"},\"wordCount\":507,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NjI0OCM0Mjg1NTg1IzIwMjA2Njk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\\\/\",\"name\":\"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Athira Pharma, Inc. - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NjI0OCM0Mjg1NTg1IzIwMjA2Njk=\",\"datePublished\":\"2021-07-07T02:14:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NjI0OCM0Mjg1NTg1IzIwMjA2Njk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NjI0OCM0Mjg1NTg1IzIwMjA2Njk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Athira Pharma, Inc.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Athira Pharma, Inc. - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/","og_locale":"en_US","og_type":"article","og_title":"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Athira Pharma, Inc. - Market Newsdesk","og_description":"NEW YORK, July 06, 2021 (GLOBE NEWSWIRE) &#8212; The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Western District of Washington on behalf of those who acquired Athira Pharma, Inc. (\u201cAthira\u201d or the \u201cCompany\u201d) (NASDAQ: ATHA) securities from September 18, 2020 through June 17, 2021, inclusive (the \u201cClass Period\u201d). Investors have until August 24, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit. In September 2020, the Company closed its initial public offering, in which the Company sold and issued 12,000,000 shares of common stock at a price to the public of $17.00 per share. In January 2021, the Company &hellip; Continue reading \"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Athira Pharma, Inc.\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-07T02:14:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NjI0OCM0Mjg1NTg1IzIwMjA2Njk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Athira Pharma, Inc.","datePublished":"2021-07-07T02:14:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/"},"wordCount":507,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NjI0OCM0Mjg1NTg1IzIwMjA2Njk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/","name":"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Athira Pharma, Inc. - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NjI0OCM0Mjg1NTg1IzIwMjA2Njk=","datePublished":"2021-07-07T02:14:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NjI0OCM0Mjg1NTg1IzIwMjA2Njk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NjI0OCM0Mjg1NTg1IzIwMjA2Njk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-kirby-mcinerney-llp-announces-the-filing-of-a-securities-class-action-lawsuit-against-athira-pharma-inc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Athira Pharma, Inc."}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/510051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=510051"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/510051\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=510051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=510051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=510051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}